 |
Burden of Urologic Diseases in America
Mark S. Litwin, M.D.
|
|
|
|
|
|
Adolescent Variocele: In Whom? How? Why the Approach
Israel Franco, M.D.
|
|
|
|
|
|
Continent Catheterizable Channels: Management of Their Complications
John C. Pope, M.D.
|
|
|
|
|
|
Spare the Rod: Pharmaceuticals or Stone Passage
Stephen Y. Nakada, M.D.
|
|
|
|
|
|
SWL: A Problem of Technology or Technique?
James E. Lingeman, M.D.
|
|
|
|
|
|
The Urologists Approach to Pelvic Pain Syndrome in Women
Philippe Zimmern, M.D.
|
|
|
|
|
|
How We Should Manage Complicated UTIs in the Debilitated Patient: The Role of Antibiotics, Biofilm Therapy, Stents
Anthony J. Schaeffer, M.D.
|
|
|
|
|
|
Lichen Sclerosis: A New Epidemic?
Andrew C. Peterson, M.D.
|
|
|
|
|
|
Treating SUI with Stem Cells
Larissa V. Rodriguez, M.D.
|
|
|
|
|
|
The AUA Guidelines: Progress and Challenges
Roger R. Dmochowski, M.D.
|
|
|
|
|
|
Emerging Toxicities of Hormonal Therapy
Matthew R. Smith, M.D., Ph.D.
MGH Cancer Center, Boston. Massachusetts
|
|
|
|
|
|
Cancer Nanotechnology: Multifunctional Nanoparticles for Prostate Cancer Therapy
Omid C. Farokhzad, M.D.
|
|
|
|
|
|
What are the Most Important On-going Clinical Trials in Urologic Oncology Worldwide?
Howard M. Sandler, M.D.
|
|
|
|
|
|
Immune-based Approaches to Prostate Cancer
Charles Drake, M.D., Ph.D.
|
|
|
|
|
|
What are the Most Important On-going Clinical Trials in Urologic Oncology Worldwide?
E. David Crawford, M.D.
Howard M. Sandler, M.D. (RTOG, EORTC, Others)
|
|
|
|
|
|
Adult Stem Cell Therapy for Erectile Dysfunction
Tom F. Lue, M.D.
|
|
|
|
|
|
An Evidence-based Approach to History-taking from the Infertile Man
Robert E. Brannigan, M.D.
|
|
|
|
|
|
Advances in Imaging for Urologic Oncology
Inderbir S. Gill, M.D.
Cleveland Clinic Foundation, Urological Institute, Cleveland, Ohio
|
|
|
|
|
|
Fundamental Issues in Geriatric Surgical Care
George W. Drach, M.D.
|
|
|
|
|
|
Advancing Urologic Research and Career Development
Robert A. Starr, M.D.
|
|
|
|
|
